Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa‐2a in HBeAg‐negative patients

Pegylated interferon alfa‐2a (PEG‐IFN) may induce sustained virological response (SVR) in 20% of hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B (CHB) patients. In addition, loss of hepatitis B surface antigen (HBsAg) is achieved with a 10% yearly rate after treatment cessation in sustain...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2009-04, Vol.49 (4), p.1151-1157
Hauptverfasser:	Moucari, Rami, Mackiewicz, Vincent, Lada, Olivier, Ripault, Marie‐Pierre, Castelnau, Corinne, Martinot‐Peignoux, Michelle, Dauvergne, Agnes, Asselah, Tarik, Boyer, Nathalie, Bedossa, Pierre, Valla, Dominique, Vidaud, Michel, Nicolas‐Chanoine, Marie‐Hélène, Marcellin, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use Biological and medical sciences DNA, Viral - blood Female Gastroenterology. Liver. Pancreas. Abdomen Hepatitis B e Antigens - blood Hepatitis B Surface Antigens - blood Hepatitis B, Chronic - drug therapy Hepatitis B, Chronic - immunology Humans Interferon-alpha - therapeutic use Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Polyethylene Glycols - therapeutic use Predictive Value of Tests Recombinant Proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!